Paramount, Comcast and Netflix are preparing bids to buy all or part of Warner Bros. Discovery, a crown jewel of the industry.
Category: Mergers, Acquisitions and Divestitures
-
Poor Countries Got $1 Trillion From China. So Did Rich Ones.
Beijing has used loans to developing nations to expand its influence, but a new study says no country has received more Chinese financing than the United States.
-
After Climate Push, Energy Companies Return to Fossil Fuels in Europe
Recent oil and gas deals in Europe suggest that the growing demand for energy may be leading companies to adopt a more pragmatic approach.
-
RedBird Capital Withdraws Takeover Bid for UK’s Telegraph
The exit by RedBird Capital Partners comes months after it agreed to buy control of the media company in a deal that valued it at $658 million.
-
A BlackRock-Backed Roofing Conglomerate Goes Bust
Investment firms are buying and bundling contractors, leaving some workers and customers worse off.
-
A MAGA Senator Promised Hope for a Dying Ohio Mill. Then Reality Set In.
The town’s unionized workers wanted to believe that there was something better than what private equity owners had offered.
-
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.
-
Pizza Hut’s Parent Yum! Brands Says Struggling Chain May Need New Owner
Yum! Brands, which also owns Taco Bell and KFC, said it would explore “strategic options” for the pizza chain.
-
The Gamble Behind a Takeover of Kenvue, Maker of Tylenol
Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they’re manageable.
-
Starbucks to Sell 60% of Its China Business to a Private Equity Firm
Boyu Capital will pay $4 billion for a stake in the coffee giant’s 8,000 stores in China.
-
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm
The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.